InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (49 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
49
T+90 hit rate
100%
T+90 mean return
+0.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Crowley John F, Executive Chairman, Amicus Therapeutics, Inc.. Officer active across 3 companies, notably Amicus Therapeutics, INC.. Cumulatively, 75 filings have been published. Breakdown: 1 buy · 49 sells. Total volume traded: €7.3m. History available since 3 May 2021. The latest transaction was disclosed on 9 January 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Crowley John F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations75 total
57,620 shares0Common StockSEC:0000950170-24-032406:0
29,181 shares@ US$13.34922.8% of flowCommon StockSEC:0000950170-24-026265:0
31,614 shares@ US$13.80883.2% of flowCommon StockSEC:0000950170-24-017264:0
94,969 shares@ US$14.009.7% of flowCommon StockSEC:0000950170-24-017264:1
31,614 shares@ US$12.61842.9% of flowCommon StockSEC:0000950170-24-011433:0
55,327 shares@ US$12.36214.9% of flowCommon StockSEC:0000950170-24-007065:0
31,614 shares@ US$12.78252.9% of flowCommon StockSEC:0000950170-24-005451:0
36,865 shares@ US$13.653.6% of flowCommon StockSEC:0000950170-24-004042:0
10,659 shares@ US$13.441.0% of flowCommon StockSEC:0000950170-24-002582:0
144,628 shares0Common StockSEC:0000950170-24-002130:0
6,043 shares@ US$12.66190.5% of flowCommon StockSEC:0000950170-23-071631:0
34,572 shares0Common StockSEC:0000950170-23-071631:1
6,043 shares@ US$11.080.5% of flowCommon StockSEC:0000950170-23-068254:0
6,043 shares@ US$10.83850.5% of flowCommon StockSEC:0000950170-23-064910:0
6,044 shares@ US$10.97410.5% of flowCommon StockSEC:0000950170-23-058953:0
6,044 shares@ US$10.49790.5% of flowCommon StockSEC:0000950170-23-054012:0
4,444 shares@ US$11.0790.4% of flowCommon StockSEC:0001209191-23-052110:0
6,044 shares@ US$13.06480.8% of flowCommon StockSEC:0001209191-23-049782:0
6,044 shares@ US$12.97940.6% of flowCommon StockSEC:0001209191-23-048461:0
6,044 shares@ US$13.02680.6% of flowCommon StockSEC:0001209191-23-046081:0
6,044 shares@ US$13.35480.6% of flowCommon StockSEC:0001209191-23-044494:0
6,044 shares@ US$13.44530.6% of flowCommon StockSEC:0001209191-23-042773:0
6,044 shares@ US$12.31070.5% of flowCommon StockSEC:0001209191-23-041658:0
6,044 shares@ US$13.040.6% of flowCommon StockSEC:0001209191-23-038515:0
4,425 shares0Common StockSEC:0001209191-23-037879:0
25 of 75 declarations
About Crowley John F
Crowley John F is Executive Chairman at Amicus Therapeutics, INC., and a Director at Intellia Therapeutics, Inc. and Entrada Therapeutics, Inc. The record shows 75 filings in total, and across the 75 sampled filings between 2021-05-05 and 2024-03-15, the reported volumes are 42735 in buys and 7276147 in sells, with Cession as the dominant transaction nature.
